Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for GKB Ophthalmics's Pretax Margin % or its related term are showing as below:
BOM:533212'
s Pretax Margin % Range Over the Past 10 Years
Min: -6.17 Med: -1.57 Max: 3.97
Current: 2.08
BOM:533212's Pretax Margin % is ranked worse than 50.61% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.31
vs BOM:533212: 2.08
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
GKB Ophthalmics Pretax Margin % Related Terms
GKB Ophthalmics Pretax Margin % Historical Data
* Premium members only.
The historical data trend for GKB Ophthalmics's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:533212 vs ISRG, BDX, MDLN: Pretax Margin % Comparison
For the Medical Instruments & Supplies subindustry, GKB Ophthalmics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GKB Ophthalmics Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GKB Ophthalmics's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where GKB Ophthalmics's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GKB Ophthalmics (BOM:533212) has a Pretax Margin % of 3.61% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on GKB Ophthalmics and its competitors. According to the industry distribution chart, GKB Ophthalmics ranks #413 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 50.6%.
Is GKB Ophthalmics' Pretax Margin % too high?
GKB Ophthalmics' current Pretax Margin % is 3.61%. The Medical Devices & Instruments industry median Pretax Margin % is 2.31. GKB Ophthalmics' value of 3.61% is 56.3% above this industry median. Based on the distribution chart, GKB Ophthalmics ranks #413 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, GKB Ophthalmics has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GKB Ophthalmics' Pretax Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, GKB Ophthalmics ranks #413 out of 816 companies for Pretax Margin %. This places GKB Ophthalmics in the lower half of its industry. The industry median Pretax Margin % is 2.31. GKB Ophthalmics' value of 3.61% is 56.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.31, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GKB Ophthalmics's current Pretax Margin % of 3.61% is 56.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on GKB Ophthalmics and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GKB Ophthalmics's current Pretax Margin % is 3.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GKB Ophthalmics stock overvalued right now?
Based on GuruFocus' analysis, GKB Ophthalmics (BOM:533212) is currently considered Possible Value Trap. The stock's GF Value™ is ₹162.30, compared to a current price of ₹59.46 — trading 63.4% below its estimated fair value. The current Pretax Margin % is 3.61% and 56.3% above the Medical Devices & Instruments industry median of 2.31. GKB Ophthalmics' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For GKB Ophthalmics (BOM:533212), the current Pretax Margin % is 3.61% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GKB Ophthalmics (BOM:533212) Overvalued in 2026?
Based on GuruFocus' analysis, GKB Ophthalmics stock appears to be undervalued.
The current stock price of ₹59.46 is trading 63.4% below its estimated GF Value™ of ₹162.30.
GuruFocus considers GKB Ophthalmics to be Possible Value Trap.
Key valuation signals for BOM:533212:
Pretax Margin %: 3.61%
GF Value™: ₹162.30 vs. price of ₹59.46 (63.4% below fair value)
Industry Position: 56.3% above the Medical Devices & Instruments median (#413 of 816)
No single metric tells the full story. See the BOM:533212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GKB Ophthalmics Ltd is an India-based company engaged in manufacturing and exporting ophthalmics lenses. It manufactures glass and plastic lenses both semi-finished and finished forms. The other products of the company include Organic lenses, Glass moulds, and Bifocal moulds. The company sells its products in India and also exports globally. Geographically, the majority of its revenue is generated from outside of India.
63GF Score
Get the complete analysis for BOM:533212
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:533212 has been successfully added to your 
